title: Natalizumab-related PML 2 weeks after negative anti-JCV antibody assay.
authors.affiliation: From the University of Washington, Seattle. mary942@hotmail.com.
authors.forename: Marie-Sarah
authors.initials: MS
authors.lastname: Gagne Brosseau
authors.affiliation: From the University of Washington, Seattle.
authors.forename: Gary
authors.initials: G
authors.lastname: Stobbe
authors.affiliation: From the University of Washington, Seattle.
authors.forename: Annette
authors.initials: A
authors.lastname: Wundes
mesh_terms: D000368:Aged; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D007577:JC Virus / Q000302:isolation & purification*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000139:chemically induced* / Q000175:diagnosis* / Q000276:immunology; D000069442:Natalizumab / Q000009:adverse effects*
chemical_list: D007155:Immunologic Factors; D000069442:Natalizumab